Brief: Venus Remedies Achieves Marketing Authorizations For Docetaxel In Israel And Cytarabine In Colombia
21/12/2023 07:42
Dec 21 (Reuters) - Venus Remedies Ltd VENR.NS :
* ACHIEVES MARKETING AUTHORIZATIONS FOR DOCETAXEL IN ISRAEL
AND
CYTARABINE IN COLOMBIA
Source text for Eikon: ID:nBSE1gSKBR
Further company coverage: VENR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage